629 related articles for article (PubMed ID: 17397237)
21. Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
Oloff S; Mailman RB; Tropsha A
J Med Chem; 2005 Nov; 48(23):7322-32. PubMed ID: 16279792
[TBL] [Abstract][Full Text] [Related]
22. Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.
Corti G; Maestrelli F; Cirri M; Zerrouk N; Mura P
Eur J Pharm Sci; 2006 Mar; 27(4):354-62. PubMed ID: 16364612
[TBL] [Abstract][Full Text] [Related]
23. Characterization of skin penetration processes of organic molecules using molecular similarity and QSAR analysis.
Santos-Filho OA; Hopfinger AJ; Zheng T
Mol Pharm; 2004; 1(6):466-76. PubMed ID: 16028358
[TBL] [Abstract][Full Text] [Related]
24. In vitro models for the blood-brain barrier.
Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
[TBL] [Abstract][Full Text] [Related]
25. A study of the relationship between cornea permeability and eye irritation using membrane-interaction QSAR analysis.
Li Y; Liu J; Pan D; Hopfinger AJ
Toxicol Sci; 2005 Dec; 88(2):434-46. PubMed ID: 16162848
[TBL] [Abstract][Full Text] [Related]
26. Computational prediction of oral drug absorption based on absorption rate constants in humans.
Linnankoski J; Mäkelä JM; Ranta VP; Urtti A; Yliperttula M
J Med Chem; 2006 Jun; 49(12):3674-81. PubMed ID: 16759110
[TBL] [Abstract][Full Text] [Related]
27. In silico prediction of membrane permeability from calculated molecular parameters.
Refsgaard HH; Jensen BF; Brockhoff PB; Padkjaer SB; Guldbrandt M; Christensen MS
J Med Chem; 2005 Feb; 48(3):805-11. PubMed ID: 15689164
[TBL] [Abstract][Full Text] [Related]
28. MIA-QSAR modelling of anti-HIV-1 activities of some 2-amino-6-arylsulfonylbenzonitriles and their thio and sulfinyl congeners.
Freitas MP
Org Biomol Chem; 2006 Mar; 4(6):1154-9. PubMed ID: 16525561
[TBL] [Abstract][Full Text] [Related]
29. ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine.
Hou T; Wang J; Li Y
J Chem Inf Model; 2007; 47(6):2408-15. PubMed ID: 17929911
[TBL] [Abstract][Full Text] [Related]
30. Quantitative structure-activity relationship modeling of juvenile hormone mimetic compounds for Culex pipiens larvae, with a discussion of descriptor-thinning methods.
Basak SC; Natarajan R; Mills D; Hawkins DM; Kraker JJ
J Chem Inf Model; 2006; 46(1):65-77. PubMed ID: 16426041
[TBL] [Abstract][Full Text] [Related]
31. Insights into the permeability of drugs and drug-like molecules from MI-QSAR and HQSAR studies.
Shinde RN; Srikanth K; Sobhia ME
J Mol Model; 2012 Mar; 18(3):947-62. PubMed ID: 21638045
[TBL] [Abstract][Full Text] [Related]
32. QSAR study on permeability of hydrophobic compounds with artificial membranes.
Fujikawa M; Nakao K; Shimizu R; Akamatsu M
Bioorg Med Chem; 2007 Jun; 15(11):3756-67. PubMed ID: 17418579
[TBL] [Abstract][Full Text] [Related]
33. QSAR-based permeability model for drug-like compounds.
Gozalbes R; Jacewicz M; Annand R; Tsaioun K; Pineda-Lucena A
Bioorg Med Chem; 2011 Apr; 19(8):2615-24. PubMed ID: 21458999
[TBL] [Abstract][Full Text] [Related]
34. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
35. Treating chemical diversity in QSAR analysis: modeling diverse HIV-1 integrase inhibitors using 4D fingerprints.
Iyer M; Hopfinger AJ
J Chem Inf Model; 2007; 47(5):1945-60. PubMed ID: 17661457
[TBL] [Abstract][Full Text] [Related]
36. Prediction of oral drug absorption in humans by theoretical passive absorption model.
Obata K; Sugano K; Saitoh R; Higashida A; Nabuchi Y; Machida M; Aso Y
Int J Pharm; 2005 Apr; 293(1-2):183-92. PubMed ID: 15778056
[TBL] [Abstract][Full Text] [Related]
37. kappa Nearest neighbors QSAR modeling as a variational problem: theory and applications.
Itskowitz P; Tropsha A
J Chem Inf Model; 2005; 45(3):777-85. PubMed ID: 15921467
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates.
Shen M; Xiao Y; Golbraikh A; Gombar VK; Tropsha A
J Med Chem; 2003 Jul; 46(14):3013-20. PubMed ID: 12825940
[TBL] [Abstract][Full Text] [Related]
39. Molecular modeling and simulation of Mycobacterium tuberculosis cell wall permeability.
Hong X; Hopfinger AJ
Biomacromolecules; 2004; 5(3):1066-77. PubMed ID: 15132701
[TBL] [Abstract][Full Text] [Related]
40. Comparative QSAR- and fragments distribution analysis of drugs, druglikes, metabolic substances, and antimicrobial compounds.
Karakoc E; Sahinalp SC; Cherkasov A
J Chem Inf Model; 2006; 46(5):2167-82. PubMed ID: 16995747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
